Celebrating a Decade of Excellence and Innovation in Clinical Research On April 14th, we mark a significant milestone in our journey – a decade dedicated to the pursuit of excellence in clinical research. As we reflect on the past ten years, we are filled with gratitude for the countless individuals who have contributed to our … Read more
Placebo Response Mitigation in Pain Clinical Trials If you are attending the Pain Therapeutics Summit in San Diego then do not miss this exciting Pre-Conference workshop held by Neil Singla, MD, Chief Scientific Officer, Lotus Clinical Research, LLC . “Placebo Response Mitigation in Pain Clinical Trials” promises to be an insightful session as Dr. Singla, a board-certified anesthesiologist shares … Read more
South Rampart Pharma Receives FDA Fast Track Designation NEW ORLEANS – South Rampart Pharma, a clinical-stage biopharmaceutical company targeting the safer treatment of pain, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company for SRP-001 for the treatment of acute pain. SRP-001 is a “non-opioid analgesic … Read more
Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System! We are thrilled to announce that Lotus Clinical Research has joined ETQ’s Reliance QMS. With ETQ Reliance, Lotus has digitized manual processes, centralized quality data, and automated core functions like document control and CAPA Plans. This partnership has greatly enhanced our … Read more
South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics – – Data expected in 3Q 2023 – NEW … Read more
We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her extensive experience to oversee and deliver Early Development Service (EDS) trials. With a wealth of experience and a proven track record of success in global project management and clinical study … Read more
Lotus and ERG effectively kick off their inaugural internal CRA Academy! Cassie Witte asks the creator and facilitator of the CRA Academy, Marilyn Greenwalt, and two of the Academy’s graduates Cooper Nelson and Nicole Johnson, some questions about this initiative. Interested in learning more about our CRA Academy? Check out the video below!
We are thrilled to introduce Sandra Winsett as the Director of Clinical Systems at Lotus Clinical Research! Sandra brings over 15 years of experience in the field of clinical systems as well as a deep understanding of the intersection between technology and healthcare. With a degree in Health Informatics and a proven track record of … Read more
We are delighted to announce that our Vice President of Clinical Development, Erin Tireman, Psy.D, will now be overseeing medical writing services as an expansion of her current leadership role within Lotus’ Scientific Services division.
Fast-growing CRO utilizes Veeva Vault Clinical Suite to substantially decrease startup time — Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva..
© 2023 Lotus Clinical Research, LLC. All Rights Reserved
